Analysis. Answers. Action. Saturday Night Fever. Shaka Brown Capital Congress

Similar documents
Diagnosis and Treatment of Tuberculosis, 2011

Case Study: TB-HIV co-infection

Managing Complex TB Cases Diana M. Nilsen, MD, RN

Laboratory Diagnosis and Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis Complex. Objectives

TB: Management in an era of multiple drug resistance. Bob Belknap M.D. Denver Public Health November 2012

TUBERCULOSIS. Presented By: Public Health Madison & Dane County

WSLH Testing and Surveillance Updates

Northwestern Polytechnic University

MIC = Many Inherent Challenges Sensititre MIC for Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis complex

Case presentation. Dr Connie Haley, MD, MPH Dr Gautam Kalyatanda, MD

Recognizing MDR-TB in Children. Ma. Cecilia G. Ama, MD 23 rd PIDSP Annual Convention February 2016

Diagnosis of TB: Laboratory Ken Jost Tuesday April 9, 2013

Patient History 1. Patient History 2. Social History. The Role of Surgery in the Management of TB. Reynard McDonald, MD & Paul Bolanowski, MD

Etiological Agent: Pulmonary Tuberculosis. Debra Mercer BSN, RN, RRT. Definition

Antimycobacterial drugs. Dr.Naza M.Ali lec Dec 2018

Drug susceptibility testing for tuberculosis KRISTEN DICKS, MD, MPH DUKE UNIVERSITY MEDICAL CENTER

Treatment of Active Tuberculosis

Laboratory Diagnosis for MDR TB

CHAPTER:1 TUBERCULOSIS. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY

Property of Presenter. Not for Reproduction DENVER TB COURSE: CHALLENGING CLINICAL PRESENTATIONS

Tuberculosis Facts. TB is not spread by: Sharing food and drink Shaking someone s hand Touching bed lines or toilet seats

Management of MDR TB. Dr Priscilla Rupali MD; DTM&H Professor and Head Department of Infectious Diseases Christian Medical College Vellore

Tuberculosis Reporting, Waco-McLennan County Public Health District TB Control WMCPHD (254)

Mycobacteria Diagnostic Testing in Manitoba. Dr. Michelle Alfa Medical Director, DSM Clin Micro Discipline

Ken Jost, BA, has the following disclosures to make:

TB and Comorbidities Adriana Vasquez, MD April 12, 2018

TB Intensive San Antonio, Texas November 11 14, 2014

Introduction to TB Nurse Case Management Online February 4, 11, 18 and 25, 2015

The Molecular MDR Screen is an Important Tool in the Diagnosis and Initiation of Appropriate Therapy in TB Patients in the State of Florida

Symptoms Latent TB Active TB

Tuberculosis Tools: A Clinical Update

Update on Management of

Case Presentations Part 2

Anti Tuberculosis Medications: Side Effects & adverse Events

Pyrosequencing Experience from Mumbai, India. Camilla Rodrigues MD Consultant Microbiologist Hinduja Hospital,Mumbai India

Fundamentals of Tuberculosis (TB)

Treatment of Tuberculosis

TB/HIV 2 sides of the same coin. Dr. Shamma Shetye, MD Microbiology Metropolis Healthcare, Mumbai

Drug Interactions Lisa Armitige, MD, PhD November 17, 2010

TB In Detroit 2011* Early TB: Smudge Sign. Who is at risk for exposure to or infection with TB? Who is at risk for TB after exposure or infection?

Rapid Diagnosis and Detection of Drug Resistance in Tuberculosis

Case Study: TB-HIV co-infection

MULTIDRUG- RESISTANT TUBERCULOSIS. Dean Tsukayama Hennepin County Medical Center Hennepin County Public Health Clinic

Diagnosis of drug resistant TB

Tuberculosis and Diabetes Mellitus. Lana Kay Tyer, RN MSN WA State Department of Health TB Nurse Consultant

TUBERCULOSIS. By Dr. Najaf Masood Assistant Prof Pediatrics Benazir Bhutto Hospital Rawalpindi

Surgery for MDR/XDR Tuberculosis

Case 1: Clinical Presentation

What you need to know about diagnosing and treating TB: a preventable, fatal disease. Bob Belknap M.D. Denver Public Health November 2014

Tuberculosis 6/7/2018. Objectives. What is Tuberculosis?

At the end of this session, participants will be able to:

Epidemiology and diagnosis of MDR-TB in children H Simon Schaaf

New Tuberculosis Guidelines. Jason Stout, MD, MHS

TB Intensive San Antonio, Texas May 7-10, 2013

Diagnosis and Medical Management of Latent TB Infection

Molecular tests for rapid detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis.

Characteristics of Mycobacterium

TB Intensive San Antonio, Texas November 11 14, 2014

Questions and Answers About

Elizabeth A. Talbot MD Assoc Professor, ID and Int l Health Deputy State Epidemiologist, NH GEISELMED.DARTMOUTH.EDU GEISELMED.DARTMOUTH.

TB Intensive San Antonio, Texas. TB/HIV Co-Infection. Lisa Armitige, MD, PhD has the following disclosures to make:

Debbie Onofre, RN, BSN March 18, TB Nurse Case Management March 17 19, 2015 San Antonio, Texas

Questions and Answers About

Supplementary Appendix

TB Nurse Assessment. Ginny Dowell, RN, BSN October 21, 2015

CDC s Approach to Fast Track Laboratory Diagnosis for Persons at Risk of Drug Resistant TB: Molecular Detection of Drug Resistance (MDDR) Service

Management of Drug-resistant Tuberculosis (DR-TB)

Tuberculosis in Chicago 2007

Tuberculosis Populations at Risk

Harmonizing the Use of Molecular & Culture-based DST of Mycobacterium tuberculosis

Scott Lindquist MD MPH Tuberculosis Medical Consultant Washington State DOH and Kitsap County Health Officer

The ABC s of AFB s Laboratory Testing for Tuberculosis. Gary Budnick Connecticut Department of Public Health Mycobacteriology Laboratory

What Is TB? 388 How TB Is Spread 388 How to Know if a Person Has TB 389 How to Treat TB 389 Resistance to TB medicines 390

Diagnosis of TB: Laboratory Ken Jost Tuesday April 1, 2014

TB Grand Rounds. Reynard McDonald, MD & Henry Fraimow, MD January 30, Outline

Managing the Patients Response to TB Treatment

TB Clinical Guidelines: Revision Highlights March 2014

CDC IMMIGRATION REQUIREMENTS:

Chapter 4 Diagnosis of Tuberculosis Disease

Diagnosis and Management of TB Disease Lisa Armitige, MD, PhD September 27, 2011

Mycobacterium tuberculosis

What you need to know about diagnosing and treating TB: a preventable, fatal disease. Bob Belknap M.D. Denver Public Health November 2013

TB BASICS: PRIORITIES AND CLASSIFICATIONS

TB Nurse Case Management. March 7-9, Diagnosis of TB: Ken Jost Wednesday March 7, 2012

10/3/2017. Updates in Tuberculosis. Global Tuberculosis, WHO 2015 report. Objectives. Disclosures. I have nothing to disclose

When good genes go bad

Mycobacterial cell wall. Cell Cycle Lengths. Outline of Laboratory Methods. Laboratory Methods

Tuberculosis Intensive

Case 1. Background. Presenting Symptoms. Schecter Case1 Differential Diagnosis of TB 1

TB in the Patient with HIV

Diagnosis & Medical Case Management of TB Disease. Lisa Armitige, MD, PhD October 22, 2015

Case Study 2016 Wisconsin Mycobacteriology Laboratory Network Annual Conference November 17, 2016

TUBERCULOSIS. What you need to know BECAUSE...CARING COMES NATURALLY TO US

Errors in Dx and Rx of TB

3/25/2012. numerous micro-organismsorganisms

Latent TB, TB and the Role of the Health Department

Treatment of TB Infection Lisa Y. Armitige, MD, PhD April 7, 2015

Contact Investigation and Prevention in the USA

TB: A Supplement to GP CLINICS

Transcription:

Saturday Night Fever Shaka Brown Capital Congress

Shaka Zulu October 31, 2012

SICK SUCKS How my illness started

October 2013

August to October 2013 Symptoms: Severe fatigue Night sweats Low grade fever Weight loss 50 lbs in 3 months Did not seek medical attention And then

October 8, 2013

Visit to the doctor Visited primary care physician (PCP) Diagnosed with epididymitis treated with ciprofloxacin Other testing performed, all negative - including HIV testing Mild improvement but still had severe fatigue and weakness Returned to PCP who provided a letter and instructions to visit the Emergency Department (ED)

THE DIAGNOSIS Hospital course

Hospital Course Admission notes Presented to the ED on 11/14/2013: fever, shortness of breath with dry cough, 50 lb. weight loss over 3 months, and testicular infection with ongoing edema MEDICATIONS: none ALLERGIES: none PMH (Past Medical History): negative PSH (Past Surgical History): negative SOCIAL HISTORY: AA male born in US. Travel to more than 37 countries as international dancer. Alcohol socially. Denies tobacco. Denies illicit drug use.

Chest X-ray 11/14/13

What disease process does the X-ray show? Miliary tuberculosis Miliary TB occurs when the Mycobacterium tuberculosis organism enters the bloodstream and disseminates to multiple sites in the body. The name comes from a distinctive pattern seen on the radiograph which appears as tiny spots, millet seeds, scattered throughout the lung

Laboratory Testing Given CT appearance, sputum was obtained on 11/17 RESULTS: AFB Smear (+), TB PCR (+) REFFERAL: Specimen was sent to the Florida State Public Health Laboratory where molecular MDR screen testing (by Hain MTBDRplus assay) showed no katg or inha mutations but was rpob indeterminate (wild type band missing, no mutant band present i.e. a mutation is present but it is not one of the characterized mutations detected by the Hain assay)

Hospital Course continued Placed on TB medication On 11/19/13 fell in hospital room and hit head on a trash can 11/20/13

Brain MRI 11/24/13

Is this TB as well? Just treat as TB or perform a biopsy to make sure there is no other disease process? Brain CT showed: Multiple hypodense regions in the bilateral subcortical white matter, left basal ganglia, and left middle cerebellar peduncle A slight mass effect noted on the fourth ventricle with no evidence of obstruction A steroid was added to the treatment regimen

Hospital Course continued Experiencing tingling and shooting pain in feet, imbalance and poor urine control Neurology consult concluded severe sensory abnormalities in feet bilaterally with associated gait instability and performed spinal MRI

Spine MRI 12/2/13

More TB? MRI on 12/2/13 revealed L4-5 spondylitis with paraspinal abscess with compression on S1 Three ring enhancing lesions identified within the thoracic spinal cord The lesions at T10 and T12 were felt to be intermedullary in nature Unclear whether the lesion at T5-T6 was intramedullary within the dorsal cord/or leptomeningeal in nature

Laboratory Testing REFFERAL: Specimen was sent to CDC s Molecular Detection of Drug Resistance (MDDR) Program on 12/3 for additional molecular testing which identified a CAC>AAC His526Asn rpob mutation interpreted as low level but probably clinically relevant rifampin resistant

MDR-TB? Still got to work out tho!

Laboratory Testing Conventional, growth-based testing was performed at Florida State Public Health Laboratory by Sensititre MIC method at National Jewish Health by MGIT 960, and at CDC by Middlebrook 7H10 Indirect Agar Proportion method

Treatment for MDR-TB Medications determined based on diagnosis of potentially RIF resistant, disseminated TB 1. Amikacin 1gm IV 3x weekly 2. Rifabutin 300mg PO daily 3. Isoniazid 300mg PO daily 4. Cycloserine 250mg PO daily 5. Pyridoxine 200mg PO daily 6. Levofloxacin 750mg PO daily 7. Ethambutol 1200mg PO daily 8. Pyrazinamide 1500mg PO daily

Treatment what does that look like? What is DOT?

Discharge March 2014 Packed a bag for one night stay in mid November 2013

April to July 2014 Readmitted in April with a 3-day headache and slurred speech. Brain lesion in left frontal lobe shown to have increased in size. Steroid treatment resolved symptoms (5 day hospital stay) Readmitted in July with continued and increased headaches, fatigue, lack of coordination and bilateral weakness. Large legion in left frontal lobe larger and now multilobulated, indicating that an abscess may be forming (16 day hospital stay)

Brain MRI 4/24/14 and 7/7/14

Brain lesion is not getting better! Is this IRIS or drug resistant TB? Neurosurgery was consulted to perform a left pterional craniotomy for resection of the insular mass PATHOLOGY: Necrotizing granulomatous inflammation, AFB stains (-) TB LAB: TB PCR (-) x2, AFB smear and culture (-)

July 14, 2014

July 2014 Steroids and more drugs added to the TB regimen: linezolid and ethionamide 1. Isoniazid 500mg PO daily 2. Rifabutin 300mg PO daily 3. Levofloxacin 750mg PO daily 4. Ethionamide 500mg PO BID 5. Cycloserine 250mg PO daily 6. Linezolid 300mg PO daily 7. Pyridoxine 200mg PO daily Discharged on July 23 Brain MRI repeated September 26

TB treatment is a slow process Plan for 18-month treatment from date of last culture-positive specimen on 11/20/13 5/20/2015 couldn t come fast enough It s like a marathon!

April 2015

May 2015 Successfully completed 18 months of MDR-TB treatment (and a marathon)

Thank you! Shaka Brown @shakabrown